Jinghai Hua
Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Ling Yu
Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Wenjun Xiong
Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Jianbing Zhu
Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Zhiming Gao
Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Yaofu Zheng
Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Dasong Yi
Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Xiaoping Peng
Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
Zeqi Zheng
Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China
LiveDNA: 86.36524
PDF Fulltext XML References Citation
How to cite this article
Jinghai Hua, Ling Yu, Wenjun Xiong, Jianbing Zhu, Zhiming Gao, Yaofu Zheng, Dasong Yi, Xiaoping Peng and Zeqi Zheng, 2022. Qili Qiangxin as an Adjuvant Treatment with Inotrope for Advanced Heart Failure: Retrospective Analysis. International Journal of Pharmacology, 18: 236-247.
DOI: 10.3923/ijp.2022.236.247
URL: https://scialert.net/abstract/?doi=ijp.2022.236.247
DOI: 10.3923/ijp.2022.236.247
URL: https://scialert.net/abstract/?doi=ijp.2022.236.247